Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. (Record no. 22160985)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02193 a2200673 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516114046.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201304s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1365-2133 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/j.1365-2133.2012.11186.x |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Prey, S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20130411 |
| 245 00 - TITLE STATEMENT | |
| Title | Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The British journal of dermatology |
| Date of publication, distribution, etc. | Nov 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1138-44 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzamides |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fibrosis |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Imatinib Mesylate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Platelet-Derived Growth Factor |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quality of Life |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Scleroderma, Diffuse |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Skin |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transforming Growth Factor beta |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ezzedine, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Doussau, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grandoulier, A-S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barcat, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chatelus, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diot, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Durant, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hachulla, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Korwin-Krokowski, J-D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kostrzewa, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Quemeneur, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paul, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schaeverbeke, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Seneschal, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Solanilla, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sparsa, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouchet, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lepreux, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mahon, F-X |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chene, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taïeb, A |
| 773 0# - HOST ITEM ENTRY | |
| Title | The British journal of dermatology |
| Related parts | vol. 167 |
| -- | no. 5 |
| -- | p. 1138-44 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1365-2133.2012.11186.x">https://doi.org/10.1111/j.1365-2133.2012.11186.x</a> |
| Public note | Available from publisher's website |
No items available.